Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Infectious Disease - Page 39

Infectious Disease

Titers of antibodies against SARS-CoV2 did not decline within four months
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

Titers of antibodies against SARS-CoV2 did not decline within four months

On Sept. 1, 2020, scientists at deCODE genetics in Iceland, a subsidiary of Amgen, published a study in…

Read More Titers of antibodies against SARS-CoV2 did not decline within four monthsContinue

Novavax and Canada reached agreement to acquire Novavax COVID-19 vaccine
Biotechnology | COVID-19 | Infectious Disease | Therapeutics | Vaccine

Novavax and Canada reached agreement to acquire Novavax COVID-19 vaccine

On Aug. 31, 2020, Novavax announced it had reached an agreement in principle with the Government of Canada…

Read More Novavax and Canada reached agreement to acquire Novavax COVID-19 vaccineContinue

Moderna confirmed discussions with the MHLW to supply Japan with 40 million doses of mRNA vaccine against COVID-19
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna confirmed discussions with the MHLW to supply Japan with 40 million doses of mRNA vaccine against COVID-19

On Aug. 28, 2020, Moderna confirmed that the Company was engaged in discussions with the Ministry of Health,…

Read More Moderna confirmed discussions with the MHLW to supply Japan with 40 million doses of mRNA vaccine against COVID-19Continue

Laurent Pharmaceuticals received FDA approval to initiate its COVID-19 phase 2 clinical trial in the U.S.
Biotechnology | COVID-19 | FDA | Infectious Disease | Therapeutics

Laurent Pharmaceuticals received FDA approval to initiate its COVID-19 phase 2 clinical trial in the U.S.

On Aug. 27, 2020, Laurent Pharmaceuticals announced that it had received approval from the U.S. Food and Drug…

Read More Laurent Pharmaceuticals received FDA approval to initiate its COVID-19 phase 2 clinical trial in the U.S.Continue

Momentous milestone as Africa announced eradication of wild Poliovirus
Biotechnology | Infectious Disease | Vaccine | WHO

Momentous milestone as Africa announced eradication of wild Poliovirus

On Aug. 25, 2020, the independent Africa Regional Certification Commission (ARCC) for Polio Eradication officially declared that the…

Read More Momentous milestone as Africa announced eradication of wild PoliovirusContinue

CytoDyn reached enrollment of 195 patients in its phase 3 trial for COVID-19 patients with severe-to-critical symptoms
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

CytoDyn reached enrollment of 195 patients in its phase 3 trial for COVID-19 patients with severe-to-critical symptoms

On Aug. 25, 2020, CytoDyn announced the Company had reached the requisite number of enrolled patients in its…

Read More CytoDyn reached enrollment of 195 patients in its phase 3 trial for COVID-19 patients with severe-to-critical symptomsContinue

Largest global study on hydroxychloroquine safety finds increased cardiovascular risk with azithromycin
Biotechnology | Infectious Disease | Therapeutics

Largest global study on hydroxychloroquine safety finds increased cardiovascular risk with azithromycin

On Aug. 24, 2020, the combination of hydroxychloroquine and azithromycin has been linked to significant cardiovascular risks, including…

Read More Largest global study on hydroxychloroquine safety finds increased cardiovascular risk with azithromycinContinue

University of Oxford study described which cancer patients are more vulnerable to COVID-19
Biotechnology | COVID-19 | Disease | Infectious Disease | Oncology | Therapeutics

University of Oxford study described which cancer patients are more vulnerable to COVID-19

On Aug. 24, 2020, a published study led by the Universities of Oxford and Birmingham found that, compared…

Read More University of Oxford study described which cancer patients are more vulnerable to COVID-19Continue

Novavax initiated phase 2 portion of phase 1/2 clinical trial of COVID-19 vaccine
Biotechnology | COVID-19 | Infectious Disease | Nanotechnology | Vaccine

Novavax initiated phase 2 portion of phase 1/2 clinical trial of COVID-19 vaccine

On Aug. 24, 2020, Novavax announced that the first volunteers were enrolled in the Phase 2 portion of…

Read More Novavax initiated phase 2 portion of phase 1/2 clinical trial of COVID-19 vaccineContinue

Mayo Clinic discontinued enrollment in Expanded Access Program for convalescent plasma with FDA Emergency Use Authorization
Biotechnology | COVID-19 | FDA | Infectious Disease | Therapeutics

Mayo Clinic discontinued enrollment in Expanded Access Program for convalescent plasma with FDA Emergency Use Authorization

On Aug. 23, 2020, the Mayo Clinic announced that with the FDA Emergency Use Authorization of convalescent plasma,…

Read More Mayo Clinic discontinued enrollment in Expanded Access Program for convalescent plasma with FDA Emergency Use AuthorizationContinue

172 countries and multiple candidate vaccines engaged in COVID-19 vaccine Global Access Facility
Biotechnology | COVID-19 | Infectious Disease | Vaccine | WHO

172 countries and multiple candidate vaccines engaged in COVID-19 vaccine Global Access Facility

On Aug. 23, 2020, the World Heath Organization (WHO) reported that 172 economies were engaged in discussions to…

Read More 172 countries and multiple candidate vaccines engaged in COVID-19 vaccine Global Access FacilityContinue

Sorrento announced FDA IND filing for COVI-GUARD neutralizing and high potency antibody against SARS-CoV-2
Biotechnology | COVID-19 | Infectious Disease | Non-Profit Research

Sorrento announced FDA IND filing for COVI-GUARD neutralizing and high potency antibody against SARS-CoV-2

On Aug. 19, 2020, Sorrento announced that it had filed an investigational new drug application (IND) for COVI-GUARD…

Read More Sorrento announced FDA IND filing for COVI-GUARD neutralizing and high potency antibody against SARS-CoV-2Continue

UT Southwestern announced open enrollment for at-home COLCORONA clinical trial
Biotechnology | COVID-19 | Infectious Disease

UT Southwestern announced open enrollment for at-home COLCORONA clinical trial

On Aug. 19, 2020, researchers at UT Southwestern Medical Center and Texas Health Resources announced what is expected…

Read More UT Southwestern announced open enrollment for at-home COLCORONA clinical trialContinue

Novavax initiated efficacy trial of COVID-19 vaccine in South Africa
Biotechnology | COVID-19 | Infectious Disease | Nanotechnology | Vaccine

Novavax initiated efficacy trial of COVID-19 vaccine in South Africa

On Aug. 17, 2020, Novavax announced the beginning of a Phase 2b clinical trial in South Africa to…

Read More Novavax initiated efficacy trial of COVID-19 vaccine in South AfricaContinue

XBiotech announced COVID-19 candidate therapy
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

XBiotech announced COVID-19 candidate therapy

On Aug. 17, 2020, XBiotech announced that it had identified True Human antibodies that could potentially be used…

Read More XBiotech announced COVID-19 candidate therapyContinue

Vaccine refusal and measles outbreaks increased in the U.S.
Biotechnology | Diagnostics | Infectious Disease | Measles | Vaccine

Vaccine refusal and measles outbreaks increased in the U.S.

On Aug. 14, 2020, in the U.S., despite high rates of coverage (>90%) at the national level for…

Read More Vaccine refusal and measles outbreaks increased in the U.S.Continue

Novavax and UK Government announced collaboration and purchase agreement for Novavax’ COVID-19 vaccine candidate
Biotechnology | COVID-19 | Infectious Disease | Nanotechnology | Vaccine

Novavax and UK Government announced collaboration and purchase agreement for Novavax’ COVID-19 vaccine candidate

On Aug. 14, 2020, Novavax announced it had signed a Heads of Terms (Term Sheet) with the Government…

Read More Novavax and UK Government announced collaboration and purchase agreement for Novavax’ COVID-19 vaccine candidateContinue

Novavax and SK bioscience announced collaboration for Novavax COVID-19 vaccine candidate
Biotechnology | COVID-19 | Infectious Disease | Nanotechnology | Vaccine

Novavax and SK bioscience announced collaboration for Novavax COVID-19 vaccine candidate

On Aug. 13, 2020, Novavax and SK bioscience announced a development and supply agreement for the antigen component…

Read More Novavax and SK bioscience announced collaboration for Novavax COVID-19 vaccine candidateContinue

Moderna announced supply agreement with U.S. Government for initial 100 million doses of mRNA vaccine against COVID-19
Biotechnology | Infectious Disease | Vaccine

Moderna announced supply agreement with U.S. Government for initial 100 million doses of mRNA vaccine against COVID-19

On Aug. 11, 2020, Moderna announced that the U.S. government had secured 100 million doses of mRNA-1273. The…

Read More Moderna announced supply agreement with U.S. Government for initial 100 million doses of mRNA vaccine against COVID-19Continue

Scientists revealed structural details of spike protein used in leading COVID-19 vaccine
Biotechnology | COVID-19 | Infectious Disease | Nanotechnology | Vaccine

Scientists revealed structural details of spike protein used in leading COVID-19 vaccine

On Aug. 7, 2020, scientists at Scripps Research announced they had obtained high-resolution, atomic-scale details of the structure…

Read More Scientists revealed structural details of spike protein used in leading COVID-19 vaccineContinue

Novavax and Takeda announced collaboration for Novavax COVID-19 vaccine candidate in Japan
Biotechnology | COVID-19 | Infectious Disease | Nanotechnology | Pharmaceutical | Vaccine

Novavax and Takeda announced collaboration for Novavax COVID-19 vaccine candidate in Japan

On Aug. 7, 2020, Novavax and Takeda Pharmaceutical announced a partnership for the development, manufacturing and commercialization of…

Read More Novavax and Takeda announced collaboration for Novavax COVID-19 vaccine candidate in JapanContinue

Novavax signed COVID-19 vaccine supply deal with India’s Serum Institute
Biotechnology | COVID-19 | Infectious Disease | Nanotechnology | Therapeutics | Vaccine

Novavax signed COVID-19 vaccine supply deal with India’s Serum Institute

On Aug. 6, 2020, Novavax announced it had entered a supply and license agreement with the Serum Institute…

Read More Novavax signed COVID-19 vaccine supply deal with India’s Serum InstituteContinue

NIH-Moderna investigational COVID-19 vaccine showed promise in mouse studies
Biotechnology | COVID-19 | Infectious Disease | Vaccine

NIH-Moderna investigational COVID-19 vaccine showed promise in mouse studies

On Aug. 5, 2020, the National Institute of Allergy and Infectious Diseases (NIAID) announced that the investigational vaccine…

Read More NIH-Moderna investigational COVID-19 vaccine showed promise in mouse studiesContinue

Novavax announced positive phase 1 data for its COVID-19 vaccine candidate
Biotechnology | COVID-19 | Infectious Disease | Nanotechnology | Vaccine

Novavax announced positive phase 1 data for its COVID-19 vaccine candidate

On Aug. 4, 2020, Novavax announced Phase 1 data from its Phase 1/2 randomized, observer-blinded, placebo-controlled trial of…

Read More Novavax announced positive phase 1 data for its COVID-19 vaccine candidateContinue

Pathnova Laboratories announced partnership to commercialize Todos Medicals COVID-19 and breast cancer tests in Singapore
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Oncology

Pathnova Laboratories announced partnership to commercialize Todos Medicals COVID-19 and breast cancer tests in Singapore

On Aug. 3, 2020, Todos Medical announced a partnership with PATHNOVA, a Singapore-based clinical laboratory, for the Company’s…

Read More Pathnova Laboratories announced partnership to commercialize Todos Medicals COVID-19 and breast cancer tests in SingaporeContinue

Serum Institute of India received approval to start human trials for Oxford vaccine
Biotechnology | Infectious Disease | Nanotechnology | Vaccine

Serum Institute of India received approval to start human trials for Oxford vaccine

On Aug. 1, 2020, Novavax announced it had received approval to start human trials in India for the…

Read More Serum Institute of India received approval to start human trials for Oxford vaccineContinue

Researchers reported fat-based molecules key to Zika virus infection
Biotechnology | Infectious Disease | Therapeutics

Researchers reported fat-based molecules key to Zika virus infection

On Jul. 31, 2020, researchers from the Pacific Northwest National Laboratory (PNNL) and Oregon Health & Science University…

Read More Researchers reported fat-based molecules key to Zika virus infectionContinue

Seqirus began shipping 2020/21 influenza vaccines to U.S. market
Biotechnology | Infectious Disease | Influenza | Vaccine

Seqirus began shipping 2020/21 influenza vaccines to U.S. market

On Jul. 30, 2020, Seqirus announced it had begun shipping its portfolio of seasonal influenza vaccines to customers…

Read More Seqirus began shipping 2020/21 influenza vaccines to U.S. marketContinue

INOVIO’s COVID-19 DNA vaccine INO-4800 provided protection with memory immune responses In non-human primates challenged with SARS-CoV-2 virus
Biotechnology | COVID-19 | Infectious Disease | Vaccine

INOVIO’s COVID-19 DNA vaccine INO-4800 provided protection with memory immune responses In non-human primates challenged with SARS-CoV-2 virus

On Jul. 30, 2020, INOVIO announced that its COVID-19 DNA vaccine INO-4800 targeting SARS-CoV-2 was effective in protecting…

Read More INOVIO’s COVID-19 DNA vaccine INO-4800 provided protection with memory immune responses In non-human primates challenged with SARS-CoV-2 virusContinue

BARDA procured Regeneron’s REGN-EB3 investigational Ebola treatment for national preparedness
Biotechnology | COVID-19 | FDA | Infectious Disease | Therapeutics | Vaccine

BARDA procured Regeneron’s REGN-EB3 investigational Ebola treatment for national preparedness

On Jul. 29, 2020, Regeneron announced that the Biomedical Advanced Research and Development Authority (BARDA) had entered into…

Read More BARDA procured Regeneron’s REGN-EB3 investigational Ebola treatment for national preparednessContinue

Page navigation

Previous PagePrevious 1 … 37 38 39 40 41 … 63 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search